Supplementation with RD antigens enhances the protective efficacy of BCG in tuberculous mice

被引:37
作者
Kalra, Mamta
Grover, Ajay
Mehta, Neena
Singh, Jaspreet
Kaur, Jaspreet
Sable, Suraj B.
Behera, Digambar
Sharma, Pawan
Verma, Indu [1 ]
Khuller, G. K.
机构
[1] Postgrad Inst Med Educ & Res, Dept Biochem, Chandigarh 160012, India
[2] Postgrad Inst Med Educ & Res, Dept Pulm Med, Chandigarh 160012, India
[3] Int Ctr Genet Engn & Biotechnol, Immunol Grp, New Delhi 110064, India
关键词
BCG supplementation; multicomponent vaccine; RD antigens;
D O I
10.1016/j.clim.2007.07.007
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Different combinations of ESAT-6, CFP-10, CFP-21, MPT-64, encoded by RD1 and RD2 of Mycobacterium tuberculosis were evaluated on the basis of antigenicity in PPD positive TB contacts and immunogenicity in C57BL/6J mice immunized with the combination of ail four RD antigens. The peripheral blood mononuclear cells of TB contacts showed maximum recognition in response to the combination of ESAT-6 + MPT-64 in terms of predominant lymphoproliferation, IFN-gamma levels and the number of responders. On the contrary, the combination of ESAT-6 + CFP-21 + MPT-64 was found to be most immunogenic based on both T-cell and antibody responses in immunized mice. Prophylactic potential of the selected combinations was assessed as supplementation vaccines to BCG against intravenous challenge with M. tuberculosis in mice. BCG supplementation with the selected combinations resulted in significantly greater protection as compared to BCG alone against experimental tuberculosis and thus appears to be a promising approach to enhance the protective efficacy of the existing vaccine. (C) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:173 / 183
页数:11
相关论文
共 52 条
[1]   TB vaccines: progress and problems [J].
Andersen, P .
TRENDS IN IMMUNOLOGY, 2001, 22 (03) :160-168
[2]   Specific immune-based diagnosis of tuberculosis [J].
Andersen, P ;
Munk, ME ;
Pollock, JM ;
Doherty, TM .
LANCET, 2000, 356 (9235) :1099-1104
[3]  
[Anonymous], 2005, GLOBAL TUBERCULOSIS
[4]   Comparative genomics of BCG vaccines by whole-genome DNA microarray [J].
Behr, MA ;
Wilson, MA ;
Gill, WP ;
Salamon, H ;
Schoolnik, GK ;
Rane, S ;
Small, PM .
SCIENCE, 1999, 284 (5419) :1520-1523
[5]   Correlation between BCG genomics and protective efficacy [J].
Behr, MA .
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 2001, 33 (04) :249-252
[6]   HUMAN T-CELL RESPONSES TO SECRETED ANTIGEN FRACTIONS OF MYCOBACTERIUM-TUBERCULOSIS [J].
BOESEN, H ;
JENSEN, BN ;
WILCKE, T ;
ANDERSEN, P .
INFECTION AND IMMUNITY, 1995, 63 (04) :1491-1497
[7]   ESAT-6 subunit vaccination against Mycobacterium tuberculosis [J].
Brandt, L ;
Elhay, M ;
Rosenkrands, I ;
Lindblad, EB ;
Andersen, P .
INFECTION AND IMMUNITY, 2000, 68 (02) :791-795
[8]  
Brosch R, 2000, INT J MED MICROBIOL, V290, P143
[9]   Combined DNA vaccines formulated in DDA enhance protective immunity against tuberculosis [J].
Cai, H ;
Tian, X ;
Hu, XD ;
Zhuang, YH ;
Zhu, YX .
DNA AND CELL BIOLOGY, 2004, 23 (07) :450-456
[10]  
COLDITZ GA, 1995, PEDIATRICS, V96, P29